BioVersys AG (SWX:BIOV)
Switzerland
· Delayed Price · Currency is CHF
29.90
+0.40 (1.36%)
Last updated: Apr 28, 2026, 4:36 PM CET
BioVersys AG Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Market Capitalization | 175 | 143 | - | - |
| Enterprise Value | 114 | 69 | - | - |
| Last Close Price | 29.90 | 24.40 | - | - |
| PS Ratio | 55.07 | 44.94 | - | - |
| PB Ratio | 2.92 | 2.39 | - | - |
| P/TBV Ratio | 2.92 | 2.39 | - | - |
| EV/Sales Ratio | 35.93 | 21.69 | - | - |
| Debt / Equity Ratio | 0.36 | 0.36 | 1.59 | 1.86 |
| Net Debt / Equity Ratio | -1.02 | -1.02 | -1.46 | -1.45 |
| Net Debt / EBITDA Ratio | 3.06 | 3.06 | 0.84 | 0.71 |
| Net Debt / FCF Ratio | 2.74 | 2.74 | 1.00 | 1.06 |
| Asset Turnover | 0.05 | 0.05 | 0.04 | - |
| Quick Ratio | 9.55 | 9.55 | 3.51 | 3.25 |
| Current Ratio | 10.10 | 10.10 | 3.56 | 3.59 |
| Return on Equity (ROE) | -61.93% | -61.93% | -194.40% | - |
| Return on Assets (ROA) | -19.87% | -19.87% | -33.86% | - |
| Return on Capital Employed (ROCE) | -24.40% | -24.40% | -74.00% | -71.40% |
| Earnings Yield | -12.48% | -15.30% | - | - |
| FCF Yield | -12.67% | -15.53% | - | - |
| Buyback Yield / Dilution | -68.49% | -68.49% | -11.60% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.